Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Haeck

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Journal of the American Academy of Dermatology|December 3, 2010
Topical corticosteroids in atopic dermatitis and the risk of glaucoma and cataractsInge M Haeck, Ton J Rouwen, Linda Timmer-de Mik, et al.
The British Journal of Dermatology|January 6, 2009
First experience with enteric-coated mycophenolate sodium (Myfortic) in severe recalcitrant adult atopic dermatitis: an open label studyS G A van Velsen, I M Haeck, C A F M Bruijnzeel-Koomen, et al.
The Journal of Dermatological Treatment|January 25, 2011
The potency of clobetasol propionate: serum levels of clobetasol propionate and adrenal function during therapy with 0.05% clobetasol propionate in patients with severe atopic dermatitisSara G A van Velsen, Marlise P De Roos, Inge M Haeck, et al.
Pediatric Dermatology|August 28, 2010
The Self-administered Eczema Area and Severity Index in children with moderate to severe atopic dermatitis: better estimation of AD body surface area than severitySara G A van Velsen, Mirjam J Knol, Inge M Haeck, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|January 31, 2026
Addressing potential bias when assessing safety of biologics and JAK inhibitors in atopic dermatitisLian F van der Gang, Keneshka Atash, Nicolaas P A Zuithoff, et al.
Journal of the American Academy of Dermatology|March 17, 2012
Two-year assessment of effect of topical corticosteroids on bone mineral density in adults with moderate to severe atopic dermatitisSara G A van Velsen, Inge M Haeck, Mirjam J Knol, et al.
Journal of the American Academy of Dermatology|April 5, 2011
Enteric-coated mycophenolate sodium versus cyclosporin A as long-term treatment in adult patients with severe atopic dermatitis: a randomized controlled trialInge M Haeck, Mirjam J Knol, Onno Ten Berge, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|January 28, 2012
Moderate correlation between quality of life and disease activity in adult patients with atopic dermatitisI M Haeck, O ten Berge, S G A van Velsen, et al.
Acta Dermato-Venereologica|August 12, 2025
Topical Steroid Withdrawal: Perspectives of Dutch Healthcare ProfessionalsFlorence Vroman, Charlotte S Schimmel, Lisa P Van der Rijst, et al.
The British Journal of Dermatology|February 15, 2007
Low basal serum cortisol in patients with severe atopic dermatitis: potent topical corticosteroids wrongfully accusedI M Haeck, L Timmer-de Mik, E G W M Lentjes, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Journal of the American Academy of Dermatology|December 3, 2010
Topical corticosteroids in atopic dermatitis and the risk of glaucoma and cataractsInge M Haeck, Ton J Rouwen, Linda Timmer-de Mik, et al.
The British Journal of Dermatology|January 6, 2009
First experience with enteric-coated mycophenolate sodium (Myfortic) in severe recalcitrant adult atopic dermatitis: an open label studyS G A van Velsen, I M Haeck, C A F M Bruijnzeel-Koomen, et al.
The Journal of Dermatological Treatment|January 25, 2011
The potency of clobetasol propionate: serum levels of clobetasol propionate and adrenal function during therapy with 0.05% clobetasol propionate in patients with severe atopic dermatitisSara G A van Velsen, Marlise P De Roos, Inge M Haeck, et al.
Pediatric Dermatology|August 28, 2010
The Self-administered Eczema Area and Severity Index in children with moderate to severe atopic dermatitis: better estimation of AD body surface area than severitySara G A van Velsen, Mirjam J Knol, Inge M Haeck, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|January 31, 2026
Addressing potential bias when assessing safety of biologics and JAK inhibitors in atopic dermatitisLian F van der Gang, Keneshka Atash, Nicolaas P A Zuithoff, et al.
Journal of the American Academy of Dermatology|March 17, 2012
Two-year assessment of effect of topical corticosteroids on bone mineral density in adults with moderate to severe atopic dermatitisSara G A van Velsen, Inge M Haeck, Mirjam J Knol, et al.
Journal of the American Academy of Dermatology|April 5, 2011
Enteric-coated mycophenolate sodium versus cyclosporin A as long-term treatment in adult patients with severe atopic dermatitis: a randomized controlled trialInge M Haeck, Mirjam J Knol, Onno Ten Berge, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|January 28, 2012
Moderate correlation between quality of life and disease activity in adult patients with atopic dermatitisI M Haeck, O ten Berge, S G A van Velsen, et al.
Acta Dermato-Venereologica|August 12, 2025
Topical Steroid Withdrawal: Perspectives of Dutch Healthcare ProfessionalsFlorence Vroman, Charlotte S Schimmel, Lisa P Van der Rijst, et al.
The British Journal of Dermatology|February 15, 2007
Low basal serum cortisol in patients with severe atopic dermatitis: potent topical corticosteroids wrongfully accusedI M Haeck, L Timmer-de Mik, E G W M Lentjes, et al.
Pageof 4